231 related articles for article (PubMed ID: 23910633)
1. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.
Osarogiagbon RU; Yu X
Ann Thorac Surg; 2013 Oct; 96(4):1178-1189. PubMed ID: 23910633
[TBL] [Abstract][Full Text] [Related]
2. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
[TBL] [Abstract][Full Text] [Related]
3. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
Ding H; Wang H; Xu L; Song N; Jiang G
Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
[TBL] [Abstract][Full Text] [Related]
4. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
[TBL] [Abstract][Full Text] [Related]
7. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
[TBL] [Abstract][Full Text] [Related]
8. Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; Spencer D; O'Brien T
J Thorac Oncol; 2010 Feb; 5(2):191-6. PubMed ID: 20035237
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
Kim D; Ferraris VA; Davenport D; Saha S
South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
[TBL] [Abstract][Full Text] [Related]
10. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma.
van Velzen E; de la Rivière AB; Elbers HJ; Lammers JW; van den Bosch JM
Ann Thorac Surg; 1999 Apr; 67(4):903-7. PubMed ID: 10320225
[TBL] [Abstract][Full Text] [Related]
11. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.
Merritt RE; Hoang CD; Shrager JB
Ann Thorac Surg; 2013 Oct; 96(4):1171-1177. PubMed ID: 23915591
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer.
Nomori H; Ikeda K; Mori T; Kobayashi H; Iwatani K; Kawanaka K; Shiraishi S; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):780-5. PubMed ID: 17320584
[TBL] [Abstract][Full Text] [Related]
13. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
[TBL] [Abstract][Full Text] [Related]
15. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
16. Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
Becker DJ; Levy BP; Gold HT; Sherman SE; Makarov DV; Schreiber D; Wisnivesky JP; Pass HI
Am J Clin Oncol; 2018 Aug; 41(8):820-825. PubMed ID: 28301349
[TBL] [Abstract][Full Text] [Related]
17. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.
Ray MA; Fehnel C; Akinbobola O; Faris NR; Taylor M; Pacheco A; Smeltzer MP; Osarogiagbon RU
J Thorac Oncol; 2021 May; 16(5):774-783. PubMed ID: 33588112
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
